Search Within

Maria Lia Palomba

Formats
  1. Meeting Abstract (289)
  2. Journal Article (127)
  3. Research Letter (10)
  4. Review (8)
  5. Correspondence (3)
  6. Editorial (3)
  7. Book Section (1)
  8. Conference Paper (1)
  9. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (443)
  2. Department of Medicine (443)
  3. Hematologic Malignancies, Division of (443)
  4. Lymphoma (443)
  5. Survivorship Research (205)
  6. Sloan Kettering Institute Postdocs (155)

More Groups

People
  1. Andrew Zelenetz (140)
  2. Ariela Noy (129)
  3. Paul Hamlin (123)
  4. Gilles Salles (109)
  5. Gunjan Shah (109)
  6. Steven Horwitz (109)

More People

Years
  1. 2025 (15)
  2. 2024 (57)
  3. 2023 (69)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (43)

More Years

Publications
  1. Blood (186)
  2. Journal of Clinical Oncology (37)
  3. Hematological Oncology (30)
  4. Blood Advances (19)
  5. British Journal of Haematology (14)
  6. Blood Cancer Journal (13)

More Publications

Publishers
  1. American Society of Hematology (206)
  2. Elsevier Inc. (44)
  3. American Society of Clinical Oncology (38)
  4. Nature Publishing Group (31)
  5. Wiley Blackwell (31)
  6. John Wiley & Sons (14)

More Publishers

Results (443)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of bridging therapy (BT) on lisocabtagene maraleucel (liso-cel) treatment in patients (pt) with R/R follicular lymphoma (FL)
    Meeting Abstract

    Reguera, J. L.; Garcia-Sancho, A. M.; Kuruvilla, J.; Izutsu, K.; Barbui, A. M.; Peter, B.; Mielke, S.; Palomba, M. L.; Cartron, G.; Ghesquieres, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patients (pts) with R/R large B-cell lymphoma (LBCL) treated with lisocabtagene maraleucel (liso-cel) nonconforming product (NCP) under the Expanded Access Protocol (EAP)
    Meeting Abstract

    Till, B. G.; Jacobson, C. A.; Palomba, M. L.; Abramson, J. S.; Arnason, J.; Locke, F. L.; Caimi, P. F.; Grover, N. S.; Karmali, R.; Suh, H. C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with Richter transformation (RT) from the Center for International Blood and Marrow Transplant Research (CIBMTR)
    Meeting Abstract

    Winter, A. M.; Bharadwaj, S.; Herrera, A. F.; Iragavarapu, C.; Mirza, S.; Palomba, M. L.; Patel, S. S.; Gharibo, M. M.; Bernasconi, D.; Krimmel, T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: Real-world experience from a cancer center
    Research Letter

    Zhu, M. L.; Drill, E.; Joffe, E.; Salles, G.; Rivas Delgado, A.; Zelenetz, A.; Palomba, M. L.; Arcila, M.; Dogan, A.
    Haematologica (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas
    Review

    Hu, B.; Korsos, V.; Palomba, M. L.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Journal Article

    Bantilan, K. S.; Smith, A. N.; Maurer, M. J.; Teruya-Feldstein, J.; Matasar, M. J.; Moskowitz, A. J.; Straus, D. J.; Noy, A.; Palomba, M. L.; Horwitz, S. M.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • A comparison of 3-year follow-up of ZUMA-5 (axicabtagene ciloleucel) with SCHOLAR-5 in relapsed/refractory follicular lymphoma
    Editorial

    Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Owen, J.; Kanters, S.; Bobillo, S.; Ribiero, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel in relapsed/refractory mantle cell lymphoma: Primary analysis of the mantle cell lymphoma cohort from TRANSCEND NHL 001, a phase I multicenter seamless design study
    Journal Article

    Wang, M.; Siddiqi, T.; Gordon, L. I.; Kamdar, M.; Lunning, M.; Hirayama, A. V.; Abramson, J. S.; Arnason, J.; Ghosh, N.; Mehta, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Does BTKi improve CAR T-cell therapy in MCL?
    Editorial

    Boardman, A. P.; Palomba, M. L.
    Blood (2024)

    Fulltext@MSK | Save